Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass

Bone

Volumn 50, Issue 5, 2012, Pages 1130-1134

  Anastasilakis, Athanasios D ^a   Polyzos, Stergios A ^b   Makras, Polyzois ^c   Sakellariou, Grigorios T ^a   Bisbinas, Ilias ^a   Gkiomisi, Athina ^a   Delaroudis, Sideris ^a   Gerou, Spyridon ^d   Ballaouri, Iris ^d   Oikonomou, Dimitrios ^a   Papapoulos, Socrates E ^e  

^a 424 General Army Hospital   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

^d Laboratories Analysis   (Greece)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute phase response; Bisphosphonates; Lymphocytes; Osteoporosis; Zoledronate

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CALCIUM ION; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; PARATHYROID HORMONE; PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA; ZOLEDRONIC ACID;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTHRALGIA; ARTICLE; BIOACCUMULATION; BODY TEMPERATURE; BONE MASS; CALCIUM BLOOD LEVEL; CELL SUBPOPULATION; CLINICAL TRIAL; CONTINUOUS INFUSION; DIZZINESS; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; EOSINOPHIL; EPISCLERITIS; ERYTHEMA; FATIGUE; FEMALE; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALAISE; MUSCLE CRAMP; MYALGIA; NAUSEA AND VOMITING; PARATHYROID HORMONE BLOOD LEVEL; PERIPHERAL EDEMA; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; RIGOR; SIDE EFFECT; SYMPTOMATOLOGY; SYNCOPE; TREATMENT DURATION; TREMOR; UVEITIS; VISUAL ANALOG SCALE; VITAMIN BLOOD LEVEL;

ACUTE-PHASE REACTION; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; INJECTIONS, INTRAVENOUS; LOGISTIC MODELS; MIDDLE AGED; ORGAN SIZE; POSTMENOPAUSE;

EID: 84859430673     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.02.006     Document Type: Article

References (21)

1. Adami S., Bhalla A., Dorizzi R., Montesanti F., Rosini S., Salvagno G., et al. The acute-phase response after bisphosphonate administration. Calcif Tissue Int 1987, 41:326-331.
2. Bijvoet O.L., Frijlink W.B., Jie K., van der Linden H., Meije r.C.J., Mulder H., et al. APD in Paget's disease of bone. Role of the mononuclear phagocyte system?. Arthritis Rheum 1980, 23:1193-1204.
3. Schweitzer D.H., Oostendorp-van de Ruit M., Van der Pluijm G., Lowik C.W., Papapoulos S.E. Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate. J Bone Miner Res 1995, 10:956-962.
4. Dicuonzo G., Vincenzi B., Santini D., Avvisati G., Rocci L., Battistoni F., et al. Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6. J Interferon Cytokine Res 2003, 23:649-654.
5. Thiébaud D., Sauty A., Burckhardt P., Leuenberger P., Sitzle r.L., Green J.R., et al. An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int 1997, 61:386-392.
6. Reid I.R., Gamble G.D., Mesenbrink P., Lakatos P., Black D.M. Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab 2010, 95:4380-4387.
7. van Beek E., Pieterman E., Cohen L., Löwik C., Papapoulos S. Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates. Biochem Biophys Res Commun 1999, 264:108-111.
8. Roelofs A.J., Jauhiainen M., Mönkkönen H., Rogers M.J., Mönkkönen J., Thompson K. Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP. Br J Haematol 2009, 144:245-250.
9. Thompson K., Rogers M.J. Statins prevent bisphosphonate- induced gdT-cell proliferation and activation in vitro. J Bone Miner Res 2004, 19:278-288.
10. Silverman S.L., Kriegman A., Goncalves J., Kianifard F., Carlson T., Leary E. Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid. Osteoporos Int 2011, 22:2337-2345.
11. Makras P., Anastasilakis A.D., Polyzos S.A., Bisbinas I., Sakellariou G.T., Papapoulos S.E. No effect of rosuvastatin in the zoledronate-induced acute phase response. Calcif Tissue Int 2011, 88:402-408.
12. Srivastava T., Dai H., Haney C.J., Alon U.S. Serum 25-hydroxyvitamin D level and acute-phase reaction following initial intravenous bisphosphonate. J Bone Miner Res 2011, 26:437-438.
13. Thompson K., Keech F., McLernon D.J., Vinod K., May R.J., Simpson W.G., et al. Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women. Bone 2011, 49:140-145.
14. Bertoldo F., Pancheri S., Zenari S., Boldini S., Giovanazzi B., Zanatta M., et al. Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion. J Bone Miner Res 2010, 25:447-454.
15. Merlotti D., Rendina D., Gennari L., Mossetti G., Gianfrancesco F., Martini G., et al. Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone. J Bone Miner Res 2011, 26:512-518.
16. Pecherstorfer M., Jilch R., Sauty A., Horn E., Keck A.V., Zimmer-Roth I., et al. Effect of first treatment with aminobisphosphonates pamidronate and ibandronate on circulating lymphocyte subpopulations. J Bone Miner Res 2000, 15:147-154.
17. Rossini M., Adami S., Viapiana O., Ortolani R., Vella A., Fracassi E., et al. Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration. J Bone Miner Res 2011, 10.1002/jbmr.521.
18. Reid D., Toole B.J., Knox S., Talwar D., Harten J., O'Reilly D.S., et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 2011, 93:1006-1011.
19. Milland J., Tsykin A., Thomas T., Aldred A.R., Cole T., Schreiber G. Gene expression in regenerating and acute-phase rat liver. Am J Physiol 1990, 259:259.
20. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010, 39:365-379.
21. Karga H., Giagourta I., Papaioannou G., Katsichti P., Pardalakis A., Kassi G., et al. Transient changes in thyroid functions tests after zoledronic acid infusion. Endocr J 2011, 58:969-977.